Form 8-K - Current report:
SEC Accession No. 0001193125-24-211075
Filing Date
2024-08-30
Accepted
2024-08-30 16:08:54
Documents
13
Period of Report
2024-08-29
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d888292d8k.htm   iXBRL 8-K 23891
  Complete submission text file 0001193125-24-211075.txt   145739

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA veru-20240829.xsd EX-101.SCH 2847
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE veru-20240829_lab.xml EX-101.LAB 17994
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE veru-20240829_pre.xml EX-101.PRE 11259
16 EXTRACTED XBRL INSTANCE DOCUMENT d888292d8k_htm.xml XML 3656
Mailing Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127
Business Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127 3125959123
VERU INC. (Filer) CIK: 0000863894 (see all company filings)

EIN.: 391144397 | State of Incorp.: WI | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-13602 | Film No.: 241269985
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)